Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tracks use of blue light bladder scans with Cysview in bladder cancer

Gathers information on how urologists use blue light cystoscopy with Cysview in bladder cancer.

Plain-language title generated from the registry record
Registry title: Blue Light Cystoscopy With Cysview® Registry

Key facts

Where
Atlanta, Baltimore, Birmingham, Charleston, Chicago, Columbus, Dallas, Evanston, Houston, Indianapolis, Kansas City, Los Angeles, Minneapolis, New York, Palo Alto, Phoenix, San Francisco, Seattle, Stony Brook, Washington D.C., and West Columbia, United StatesSee the 23 sites

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with suspected or known bladder cancer that has not grown into the muscle, based on an earlier cystoscopy. It gathers information on how blue light cystoscopy with Cysview is used in urologists' practices.

Age
Adults over 18 years old (minimum age 18 years)
Sex
All sexes can join.
Disease stage
Suspected or known non-muscle invasive bladder cancer, based on a prior cystoscopy.

Main reasons for not taking part

  • Porphyria
  • Gross hematuria
  • Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives

Read by machine on 12 November 2026.

Where in United States

  • Emory University School of MedicineAtlanta, United StatesContact: Vikram Narayan, MDTaking people
  • Johns Hopkins MedicineBaltimore, United StatesContact: Morgan De CarliTaking people
  • The University of Alabama at BirminghamBirmingham, United StatesContact: Charles Peyton, MDTaking people
  • Charleston Area Medical CenterCharleston, United StatesContact: Chad McKee, PhDNo longer taking part
  • Northwestern UniversityChicago, United StatesContact: Clay ArnettTaking people
  • Ohio State UniversityColumbus, United StatesContact: Rachel Link, CCRPTaking people
  • Ohio State University Wexner Medical CenterColumbus, United StatesContact: Kamal Pohar, MDTaking people
  • UT SouthwesternDallas, United StatesContact: Yair Lotan, MDTaking people
  • Northshore University Health SystemEvanston, United StatesContact: Adam VanderlooTaking people
  • Michael E. DeBakey VA Medical CenterHouston, United StatesContact: Ashley Jones, BS, CCRPTaking people
  • Indiana University School of MedicineIndianapolis, United StatesContact: Lehman G Jennifer, RN, CCRPTaking people
  • University of Kansas Medical CenterKansas City, United StatesContact: Jane LedesmaTaking people
  • University of California, Los AngelesLos Angeles, United StatesContact: Karim Chamie, MDTaking people
  • USC / Norris Comprehensive Cancer CenterLos Angeles, United StatesContact: Ileana AldanaTaking people
  • University of MinnesotaMinneapolis, United StatesContact: Maressa TwedtTaking people
  • NYU Langone's Perlmutter Cancer CenterNew York, United StatesContact: Gary Steinberg, MDTaking people
  • VA Palo Alto Health Care SystemPalo Alto, United StatesContact: Dorothy TrivediTaking people
  • Mayo ClinicPhoenix, United StatesContact: Mark Tyson, MD, MPHTaking people
  • University of California San FranciscoSan Francisco, United StatesContact: Sima Porten, MD, MPHTaking people
  • University of Washington MedicineSeattle, United StatesContact: John Gore, MDTaking people
  • Stony Brook UrologyStony Brook, United StatesContact: Chad McKee, PhDNo longer taking part
  • Sibley Memorial HospitalWashington D.C., United StatesContact: Armine Smith, MDTaking people
  • Lexington Medical CenterWest Columbia, United StatesContact: Nicol BrandonTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Photocure
Trial code
NCT02660645
Record updated
18 December 2025
Original description
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.Read full original descriptionShow less

Blue Light Cystoscopy With Cysview® Registry

Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.

Inclusion: Adult >18 years old; Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy.

Exclusion: Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives; Porphyria; Gross hematuria.

ClinicalTrials.gov NCT02660645